Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus

Hepatocellular carcinoma (HCC) has one of highest mortalities globally amongst cancers, but has limited therapeutic options once in the advanced stage. Hepatitis B or C virus infection are the most common drivers for HCC carcinogenesis, triggering chronic liver inflammation and adding to the complex...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonilla, Cecilia Monge, McGrath, Nicole A., Fu, Jianyang, Xie, Changqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597818/
https://www.ncbi.nlm.nih.gov/pubmed/33134550
http://dx.doi.org/10.20517/2394-5079.2020.58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597818/
https://www.ncbi.nlm.nih.gov/pubmed/33134550
http://dx.doi.org/10.20517/2394-5079.2020.58

Ejemplares similares